MBCL-23. HIGH-DOSE THIOTEPA, CARBOPLATIN AND ETOPOSIDE WITH AUTOLOGOUS HEMATOPOIETIC STEM-CELL TRANSPLANTATION FOR PATIENTS WITH RECURRENT MEDULLOBLASTOMA

AIM: Most patients with recurrent medulloblastoma (rMB) have very poor prognosis with only few of them achieving prolonged response to second-line conventional treatment. This study evaluates the possible role of treatment intensification with thiotepa, carboplatin and etoposide-containing high-dose...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Neuro Oncol
Hlavní autoři: Gevorgian, Asmik, Tolkunova, Polina, Iukhta, Tatiana, Kazantsev, Ilya, Morozova, Elena, Andreeva, Tatiana, Kozlov, Andrew, Safonova, Svetlana, Punanov, Yury, Zubarovskaya, Ludmila, Zheludkova, Olga, Afanasyev, Boris
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2018
Témata:
Abstracts
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6012920/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy059.419
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky